# A New Treatment Option for Heavy Menstrual Bleeding

> **NCT01715025** · PHASE4 · UNKNOWN · sponsor: **Sydney Centre for Reproductive Health Research** · enrollment: 30 (estimated)

## Conditions studied

- Menorrhagia

## Interventions

- **DRUG:** E2Nomac

## Key facts

- **NCT ID:** NCT01715025
- **Lead sponsor:** Sydney Centre for Reproductive Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715025, "A New Treatment Option for Heavy Menstrual Bleeding". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01715025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*